Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human monoclonal antibodies fragments inhibiting both the Cath-D catalytic activity and its binding to the LRP1 receptor

Human monoclonal antibodies fragments inhibiting both the Cath-D catalytic activity and its binding to the LRP1 receptor

US Patent 10526415 · Granted Jan 7, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Monoclonal antibodies specific for IL20-Rb, encoding nucleic acids thereof and m2025
Anti-müllerian inhibiting substance antibodies and uses thereof2025
Monoclonal antibodies binding to the CD160 transmembrane isoform2021
Anti-human-HER3 antibodies and uses thereof2021
Human monoclonal antibodies against orexin receptor type 12020
Human monoclonal antibodies against AXL2019
Neuregulin allosteric anti-HER3 antibody2019
Molecules inhibiting a metabolic pathway involving the Syk protein tyrosine kina2016
Anti-Axl antibodies and uses thereof2016
Antibodies against HER32016
Anti-Axl antibodies and uses thereof2016
Anti-human HER3 antibodies and uses thereof2015